StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
68
This year
4
Publishing Date
2024 - 01 - 24
1
2023 - 12 - 08
3
2023 - 11 - 25
1
2023 - 11 - 23
1
2023 - 10 - 30
1
2023 - 10 - 20
1
2023 - 10 - 09
1
2023 - 09 - 15
1
2023 - 09 - 14
1
2023 - 09 - 04
1
2023 - 08 - 08
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 15
1
2023 - 06 - 02
1
2023 - 06 - 01
1
2023 - 05 - 25
1
2023 - 05 - 18
1
2023 - 03 - 28
1
2023 - 03 - 27
1
2023 - 02 - 28
1
2023 - 02 - 27
1
2023 - 02 - 20
1
2023 - 02 - 14
1
2023 - 02 - 10
1
2023 - 01 - 26
1
2023 - 01 - 25
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2023 - 01 - 11
1
2023 - 01 - 09
1
2022 - 12 - 30
1
2022 - 12 - 28
1
2022 - 12 - 01
1
2022 - 11 - 22
1
2022 - 09 - 28
2
2022 - 09 - 21
1
2022 - 09 - 05
1
2022 - 09 - 02
1
2022 - 08 - 25
1
2022 - 08 - 22
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 20
1
2022 - 07 - 07
1
2022 - 07 - 04
1
2022 - 06 - 27
3
2022 - 06 - 24
1
2022 - 05 - 24
1
2022 - 05 - 09
1
2022 - 04 - 26
1
2022 - 03 - 23
1
2022 - 03 - 04
1
2022 - 02 - 28
1
2021 - 11 - 02
1
2021 - 10 - 21
1
2021 - 10 - 20
1
2021 - 10 - 13
1
2021 - 10 - 06
1
2021 - 10 - 01
1
Sector
Communications
1
Consumer non-durables
1
Health services
1
Health technology
68
Manufacturing
11
N/a
6
Process industries
2
Professional, scientific, and technical services
2
Tags
Active
1
Alzheimer's
1
America
2
Antibiotics
1
Biomarkers
1
Biosimilar
1
Biotechnology
1
Breast
5
Business
2
Cancer
7
Clinical-trials-phase-iii
1
Diabetes
2
Diabetic
2
Disease
4
Drug
7
Expansion
1
Expected
5
Eye
1
Fibromyalgia
1
Glaucoma
1
Global
21
Growing
2
Growth
7
Health
1
Heart
1
Hormone
2
Immunotherapy
1
Kidney
1
Kisqali
5
Life
1
Macular
1
Market
42
Migraine
1
Muscular atrophy
1
N/a
65
Nephropathy
1
Novartis
5
Order
1
Osteoarthritis
2
People
1
Psoriasis
1
Reach
1
Report
18
Research
9
Risk
4
Roche
1
Study
3
T-cell
1
Therapeutics
8
Therapy
5
Treat
1
Treatment
15
Trial
1
Ulcerative colitis
2
Entities
3m company
8
Abbott laboratories
106
Abbvie inc.
218
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
12
Alcon inc.
14
Alkermes plc
7
Amgen inc.
168
Astellas pharma inc
70
Astrazeneca plc
172
Autolus therapeutics plc
7
Bausch health companies inc.
61
Baxter international inc.
45
Becton, dickinson and company
17
Beigene, ltd.
7
Biogen inc.
47
Biomarin pharmaceutical inc.
6
Biontech se
9
Boston scientific corporation
13
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
82
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
10
Eli lilly and company
121
Endo international plc
20
General electric company
8
Genmab a/s
12
Gilead sciences, inc.
25
Glaxosmithkline plc
265
Grifols sa
10
Incyte corporation
15
Ionis pharmaceuticals, inc.
7
Jazz pharmaceuticals plc
13
Johnson & johnson
189
Koninklijke philips n.v.
17
Mallinckrodt plc
17
Medtronic plc
29
Morphosys ag
13
Novartis ag
1035
Novo nordisk a/s
27
Orange
8
Orchard therapeutics plc
8
Perrigo company
7
Pfizer, inc.
68
Precision biosciences, inc.
8
Reckitt benckiser group plc
10
Regeneron pharmaceuticals, inc.
12
Regenxbio inc.
11
Sanofi
285
Smith & nephew plc
7
Stryker corporation
10
Takeda pharmaceutical company limited
51
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
48
Ucb s.a.
8
Viatris inc.
115
Xencor, inc.
9
Symbols
ABBV
37
ABT
32
ADCT
5
AERI
5
AGIO
10
ALKS
4
ALNY
14
ALPMF
26
ALPMY
26
AMGN
34
ARVN
24
AVEO
10
AZN
45
AZNCF
35
BAX
6
BCRX
14
BDX
6
BEAM
6
BGNE
10
BHC
5
BHVN
15
BMY
61
BNTX
95
BPMC
10
CLVS
11
ENDP
7
EPZM
11
EXEL
13
FNCTF
29
GBT
6
GILD
27
GLAXF
42
GSK
64
ILMN
12
INCY
14
IONS
5
JNJ
76
KPTI
10
LLY
80
MRNA
7
MYOV
14
NVO
11
NVS
88
NVSEF
68
OMER
13
OPK
6
OTIC
13
PFE
693
REGN
22
RIGL
11
SGEN
7
SNY
153
SNYNF
90
TAK
23
TEVJF
29
VSTM
10
VTRS
8
VYGR
6
XERS
10
YMAB
10
Exchanges
Amex
2
Nasdaq
68
Nyse
68
Crawled Date
2024 - 01 - 24
1
2023 - 12 - 08
3
2023 - 11 - 25
1
2023 - 11 - 23
1
2023 - 10 - 30
1
2023 - 10 - 20
1
2023 - 10 - 09
1
2023 - 09 - 15
1
2023 - 09 - 14
1
2023 - 09 - 04
1
2023 - 08 - 08
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 15
1
2023 - 06 - 02
1
2023 - 06 - 01
1
2023 - 05 - 25
1
2023 - 05 - 18
1
2023 - 03 - 28
1
2023 - 03 - 27
1
2023 - 02 - 28
1
2023 - 02 - 27
1
2023 - 02 - 20
1
2023 - 02 - 14
1
2023 - 02 - 11
1
2023 - 01 - 27
1
2023 - 01 - 25
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2023 - 01 - 11
1
2023 - 01 - 09
1
2022 - 12 - 30
1
2022 - 12 - 28
1
2022 - 12 - 01
1
2022 - 11 - 22
1
2022 - 09 - 28
2
2022 - 09 - 21
1
2022 - 09 - 05
1
2022 - 09 - 02
1
2022 - 08 - 25
1
2022 - 08 - 22
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 20
1
2022 - 07 - 07
1
2022 - 07 - 04
1
2022 - 06 - 27
3
2022 - 06 - 24
1
2022 - 05 - 24
1
2022 - 05 - 09
1
2022 - 04 - 26
1
2022 - 03 - 23
1
2022 - 03 - 04
1
2022 - 02 - 28
1
2021 - 11 - 02
1
2021 - 10 - 21
1
2021 - 10 - 20
1
2021 - 10 - 13
1
2021 - 10 - 06
1
2021 - 10 - 01
1
Crawled Time
00:00
2
00:20
2
01:00
2
02:00
1
04:00
1
06:00
1
07:00
1
09:00
3
10:00
6
11:00
2
12:00
11
12:20
1
13:00
3
14:00
5
14:15
1
15:00
4
15:20
1
15:30
1
16:00
5
17:00
3
18:00
3
19:00
3
21:00
1
22:00
4
23:00
1
Source
www.biospace.com
3
www.globenewswire.com
5
www.prnewswire.com
60
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Pfizer, inc.
symbols :
NVSEF
save search
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published:
2024-03-07
(Crawled : 12:00)
- prnewswire.com
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-3.2%
|
O:
0.04%
H:
0.44%
C:
-1.51%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
-3.68%
|
O:
-2.08%
H:
0.13%
C:
-0.57%
BMY
|
$48.825
-0.34%
9.7M
|
Health Technology
|
-8.22%
|
O:
0.36%
H:
0.34%
C:
-0.54%
XFOR
|
$1.26
2.44%
930K
|
Health Technology
|
27.66%
|
O:
0.12%
H:
0.0%
C:
-4.98%
EYPT
|
News
|
$16.49
-6.15%
490K
|
Health Technology
|
-31.74%
|
O:
2.56%
H:
1.37%
C:
-4.13%
AQST
|
$4.085
-4.56%
1.1M
|
Health Technology
|
-14.91%
|
O:
1.79%
H:
12.3%
C:
10.94%
ALKS
|
$24.49
0.95%
590K
|
Health Technology
|
-16.17%
|
O:
1.11%
H:
0.96%
C:
0.65%
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published:
2024-02-09
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
1.2K
|
Health Technology
|
-13.24%
|
O:
-0.91%
H:
3.88%
C:
3.88%
AZNCF
|
News
|
$140.3
1.5K
|
Health Technology
|
12.24%
|
O:
-2.6%
H:
2.26%
C:
1.44%
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
-7.06%
|
O:
-2.46%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
480K
|
Manufacturing
|
-11.56%
|
O:
4.66%
H:
0.0%
C:
-3.92%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-4.53%
|
O:
-0.04%
H:
0.11%
C:
0.0%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
-2.47%
|
O:
-0.37%
H:
0.21%
C:
0.05%
ABBV
|
News
|
$168.21
-0.78%
1.2M
|
Health Technology
|
-2.8%
|
O:
0.33%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.765
-1.94%
950K
|
Health Technology
|
2.1%
|
O:
1.11%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.26
0.58%
3.8M
|
Health Technology
|
11.54%
|
O:
-1.28%
H:
1.05%
C:
-0.72%
research
global
market
Global Sustained Release Coatings Markets, 2018-2022 and 2023-2028: Growing Demand for Controlled Drug Delivery Boosts Expansion
Published:
2024-02-01
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
2.6K
|
Health Technology
|
-4.9%
|
O:
-1.29%
H:
0.0%
C:
-1.38%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-2.81%
|
O:
0.07%
H:
0.83%
C:
0.7%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
-4.46%
|
O:
1.55%
H:
0.79%
C:
0.25%
GSK
|
News
|
$40.905
-0.81%
890K
|
Health Technology
|
4.56%
|
O:
1.27%
H:
1.87%
C:
1.73%
EMN
|
$96.335
-0.48%
300K
|
Process Industries
|
15.86%
|
O:
0.79%
H:
0.8%
C:
0.77%
drug
expansion
global
growing
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published:
2024-01-24
(Crawled : 17:00)
- prnewswire.com
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-7.42%
|
O:
0.39%
H:
0.82%
C:
-0.74%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
-8.23%
|
O:
0.22%
H:
0.43%
C:
-0.39%
SRNE
|
$0.015
56K
|
Health Technology
|
-66.67%
|
O:
-63.33%
H:
263.64%
C:
127.27%
GILD
|
$66.99
-0.06%
3.3M
|
Health Technology
|
-15.66%
|
O:
0.1%
H:
0.43%
C:
-0.04%
AUTL
|
$4.265
-4.8%
2M
|
Health Technology
|
-18.84%
|
O:
-0.91%
H:
11.52%
C:
4.94%
drug
report
t-cell
global
therapy
market
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions - December 8, 2023
Published:
2023-12-08
(Crawled : 16:00)
- biospace.com/
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
-0.9%
|
O:
-1.29%
H:
0.4%
C:
0.4%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-8.07%
|
O:
0.07%
H:
1.1%
C:
0.45%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
3.05%
|
O:
0.19%
H:
0.35%
C:
0.2%
kisqali
breast
risk
novartis
Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights (CMI)
Published:
2023-12-08
(Crawled : 15:00)
- prnewswire.com
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
|
60.0%
|
O:
-20.0%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
-0.9%
|
O:
-1.29%
H:
0.4%
C:
0.4%
PPCB
|
$0.0011
-41.86%
5.6M
|
Manufacturing
|
-88.7%
|
O:
0.0%
H:
2.61%
C:
-4.35%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-8.07%
|
O:
0.07%
H:
1.1%
C:
0.45%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
3.05%
|
O:
0.19%
H:
0.35%
C:
0.2%
active
market
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Published:
2023-12-08
(Crawled : 14:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
-0.9%
|
O:
-1.29%
H:
0.4%
C:
0.4%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-8.07%
|
O:
0.07%
H:
1.1%
C:
0.45%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
3.05%
|
O:
0.19%
H:
0.35%
C:
0.2%
kisqali
breast
risk
novartis
Global Synthetic Hormones Market Analysis and Forecast, 2023-2033: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape
Published:
2023-11-25
(Crawled : 00:20)
- prnewswire.com
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$735.1
-1.42%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
Email alert
Add to watchlist
global
market
Global Vaginitis Therapeutics Market Size Projected to Reach USD 7.20 Billion By 2032, With 8.1% CAGR Growth: Polaris Market Research
Published:
2023-11-23
(Crawled : 15:30)
- prnewswire.com
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
reach
research
global
therapeutics
market
Anti-inflammatory Therapeutics Market Size to Hit US$ 149.5 billion by 2031 | Exclusive Study by Transparency Market Research
Published:
2023-10-30
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
2.6K
|
Health Technology
|
8.56%
|
O:
-4.67%
H:
4.9%
C:
4.9%
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
9.44%
|
O:
2.76%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-12.59%
|
O:
0.43%
H:
1.46%
C:
1.03%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
7.14%
|
O:
1.69%
H:
0.25%
C:
-0.07%
JNJ
|
News
|
$148.515
-0.7%
4.3M
|
Health Technology
|
1.02%
|
O:
-1.39%
H:
0.79%
C:
0.64%
GSK
|
News
|
$40.905
-0.81%
890K
|
Health Technology
|
19.33%
|
O:
2.29%
H:
0.44%
C:
-0.23%
ABBV
|
News
|
$168.21
-0.78%
1.2M
|
Health Technology
|
23.2%
|
O:
2.87%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.765
-1.94%
950K
|
Health Technology
|
5.09%
|
O:
-0.85%
H:
0.0%
C:
0.0%
research
therapeutics
study
market
Novartis Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
Published:
2023-10-20
(Crawled : 10:00)
- globenewswire.com
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-15.61%
|
O:
-0.42%
H:
0.16%
C:
-1.32%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
4.46%
|
O:
0.6%
H:
0.61%
C:
-0.56%
kisqali
breast
cancer
risk
novartis
Dyadic Appoints Doug Pace to Its Executive Leadership Team
Published:
2023-10-09
(Crawled : 13:00)
- globenewswire.com
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-20.56%
|
O:
-0.21%
H:
1.24%
C:
0.42%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
1.77%
|
O:
0.01%
H:
0.47%
C:
0.45%
DYAI
4
|
$1.49
1.2K
|
Health Technology
|
-26.96%
|
O:
-2.45%
H:
0.0%
C:
-2.01%
RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published:
2023-09-15
(Crawled : 15:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
-13.01%
|
O:
1.53%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
13.27%
|
O:
0.79%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
480K
|
Manufacturing
|
-36.69%
|
O:
3.0%
H:
0.0%
C:
-3.43%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-22.93%
|
O:
-0.26%
H:
1.04%
C:
0.03%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
-2.92%
|
O:
1.51%
H:
0.26%
C:
-0.72%
SRPT
|
$124.02
5.89%
550K
|
Health Technology
|
-2.17%
|
O:
-0.27%
H:
0.54%
C:
-0.84%
SNY
|
News
|
$46.765
-1.94%
950K
|
Health Technology
|
-13.73%
|
O:
0.82%
H:
0.0%
C:
0.0%
MRNA
|
News
S
|
$108.57
0.63%
2.4M
|
Health Technology
|
-4.36%
|
O:
0.16%
H:
2.0%
C:
1.42%
IONS
|
$42.27
1.03%
360K
|
Health Technology
|
-4.12%
|
O:
-0.57%
H:
0.35%
C:
-1.11%
BNTX
|
News
|
$88.185
-0.35%
140K
|
Health Technology
|
-22.25%
|
O:
0.17%
H:
0.48%
C:
-0.82%
ARWR
|
$23.215
-2.38%
320K
|
Health Technology
|
-22.13%
|
O:
0.16%
H:
0.46%
C:
-5.46%
ALNY
|
$144.31
-1.21%
200K
|
Health Technology
|
-24.34%
|
O:
-0.74%
H:
2.42%
C:
-3.47%
therapeutics
market
Optic Nerves Disorder Treatment Market Rises: North America Takes the Helm
Published:
2023-09-14
(Crawled : 00:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
15.36%
|
O:
1.84%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-22.77%
|
O:
0.47%
H:
0.41%
C:
-0.26%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
-1.91%
|
O:
0.28%
H:
1.0%
C:
0.76%
ABBV
|
News
|
$168.21
-0.78%
1.2M
|
Health Technology
|
13.52%
|
O:
1.78%
H:
1.76%
C:
1.07%
america
treatment
market
Decoding the Global Vasectomy Market 2023: Trends, Strategies, and Regulatory Insights
Published:
2023-09-04
(Crawled : 16:00)
- prnewswire.com
SNY
|
News
|
$46.765
-1.94%
950K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.905
-0.81%
890K
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
Email alert
Add to watchlist
ENDP
|
News
|
$0.2926
-9.6%
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$168.21
-0.78%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$19.54
2.6K
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$106.96
-0.59%
2.6M
|
Health Technology
|
Email alert
Add to watchlist
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
|
Email alert
Add to watchlist
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$148.515
-0.7%
4.3M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
global
market
North America Kidney Transplant Research Report 2023
Published:
2023-08-08
(Crawled : 22:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
15.65%
|
O:
1.11%
H:
0.53%
C:
0.53%
ALPMY
|
News
|
$9.49
480K
|
Manufacturing
|
-36.78%
|
O:
3.93%
H:
0.0%
C:
-3.08%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-26.15%
|
O:
-0.11%
H:
1.29%
C:
0.67%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
-4.07%
|
O:
-0.07%
H:
0.73%
C:
0.36%
MDT
|
$80.37
-1.13%
2.6M
|
Health Technology
|
-3.15%
|
O:
-1.98%
H:
1.7%
C:
0.81%
SNY
|
News
|
$46.765
-1.94%
950K
|
Health Technology
|
-9.87%
|
O:
0.81%
H:
0.0%
C:
0.0%
america
report
kidney
research
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$24.49
0.95%
590K
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$148.515
-0.7%
4.3M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
|
News
M
|
$138.63
-1.04%
450K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$65.26
5.9K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$128.725
750
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
1.5K
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.265
-0.86%
540K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.825
-0.34%
9.7M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$71.26
0.58%
3.8M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$735.1
-1.42%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.765
-1.94%
950K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$168.21
-0.78%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
2.6K
|
Health Technology
|
7.57%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.265
-0.86%
540K
|
Health Technology
|
-15.38%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-28.65%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
-0.65%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$148.515
-0.7%
4.3M
|
Health Technology
|
-8.54%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
News
|
$40.905
-0.81%
890K
|
Health Technology
|
13.7%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
News
|
$735.1
-1.42%
1.2M
|
Health Technology
|
63.23%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.825
-0.34%
9.7M
|
Health Technology
|
-24.39%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
News
|
$71.26
0.58%
3.8M
|
Health Technology
|
-1.23%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
Biosimilars Market worth $66.9 billion | MarketsandMarkets
Published:
2023-06-15
(Crawled : 10:00)
- prnewswire.com
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-33.13%
|
O:
0.13%
H:
1.07%
C:
0.86%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
-0.82%
|
O:
1.04%
H:
0.78%
C:
0.67%
LLY
|
News
|
$735.1
-1.42%
1.2M
|
Health Technology
|
65.07%
|
O:
0.06%
H:
1.91%
C:
1.32%
AMGN
|
News
|
$274.15
0.22%
900K
|
Health Technology
|
23.06%
|
O:
0.33%
H:
2.62%
C:
2.43%
market
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups
Published:
2023-06-02
(Crawled : 12:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
18.53%
|
O:
0.99%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.25
-0.27%
12M
|
Health Technology
|
-30.77%
|
O:
0.6%
H:
1.07%
C:
0.29%
NVS
|
News
|
$98.1
0.84%
1.3M
|
Health Technology
|
1.8%
|
O:
1.03%
H:
0.84%
C:
0.82%
kisqali
breast
risk
novartis
← Previous
1
2
3
4
Next →
Gainers vs Losers
58%
42%
Top 10 Gainers
CZOO
|
$10.52
110.82%
10M
|
CSSE
4
|
$0.3181
108.86%
170M
|
Consumer Services
BOF
|
$1.88
60.68%
98M
|
AMST
|
$3.1
55.0%
66M
|
Technology Services
LICN
|
$0.85
51.79%
13M
|
WIMI
|
$1.03
41.99%
15M
|
Technology Services
SKIL
4
|
$8.045
40.89%
230K
|
Information
MULN
|
News
|
$3.805
39.38%
11M
|
Information
RILY
|
$30.01
38.17%
11M
|
Finance
MTC
|
$3.04
35.71%
6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.